Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE AUDIT COMMITTE 2022-06-16
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 10, 2022 2022-06-10
Next Day Disclosure Return 2022-06-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 2022-06-06
2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022-05-31
VOLUNTARY ANNOUNCEMENT - PRESENTATION OF RESEARCH UPDATES ON KN046 AND KN026 AT 2022 ASCO ANNUAL MEETING 2022-05-30
CLARIFICATION ANNOUNCEMENT 2022-05-30
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II CLINICAL TRIAL OF KN026 COMBINED WITH PALBOCICLIB AND FULVESTRANT FOR THE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER 2022-05-26
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME 2022-05-20
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 10, 2022 2022-05-10

12 13 14 15 16 17 18